Nkarta Inc. (NKTX) Social Stream



Nkarta Inc. (NKTX): $4.90

0.07 (+1.45%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

D

Add NKTX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#340 of 381

in industry

NKARTA INC (NKTX) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering NKARTA INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-10 4 $77 $71 $74.333 $4.59 1519.46%
2021-11-16 4 $75 $71 $72.333 $4.59 1475.88%
2021-11-18 5 $75 $50 $66.75 $4.59 1354.25%
2022-03-18 7 $71 $25 $48.2 $4.59 950.11%
2022-03-29 8 $71 $17 $43 $4.59 836.82%
2022-04-01 8 $71.001 $17 $43 $4.59 836.82%
2022-05-13 8 $60 $32 $44.333 $4.59 865.86%
2022-07-18 9 $60 $30 $42.285 $4.59 821.24%
2022-08-12 10 $60 $26 $40.25 $4.59 776.91%
2022-10-14 11 $50 $25 $35.875 $4.59 681.59%
2022-11-10 12 $50 $25 $33.875 $4.59 638.02%
2022-11-16 9 $38 $25 $30.142 $4.59 556.69%
2022-12-05 11 $38 $25 $30.555 $4.59 565.69%
2023-03-16 10 $38 $25 $30.142 $4.59 556.69%
2023-03-17 10 $32 $21 $27.142 $4.59 491.33%
2023-04-18 10 $32 $21 $26.857 $4.59 485.12%
2023-05-12 10 $32 $18 $26.428 $4.59 475.77%

The Trend in the Analyst Price Target


Over the past 14 months, NKTX's average price target has gone down $31.97.

NKTX reports an average of 254.24% for its upside potential over the past 43 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-08-12 10 50 26 37.428 17.37 115.47%
2022-08-12 9 50 26 37.500 17.37 115.89%
2022-10-14 11 50 25 35.875 13.29 169.94%
2022-11-16 9 38 25 30.142 9.82 206.95%
2022-11-16 10 38 25 31.125 9.82 216.96%

NKTX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.4 7 2 1 0 0 10

The Trend in the Broker Recommendations


NKTX's average broker recommendation rating improved by 0.35 over the prior 25 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • NKTX has a higher upside potential (average analyst target price relative to current price) than 3055.73% of all US stocks.
  • NKARTA INC's number of analysts covering the stock is greater than 2022.32% of stocks in the mid market cap category.
  • In terms of how NKARTA INC fares relative to stocks in the mid market cap category, note that its variance in analysts' estimates is lower than -1894.11% of that group.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, NKARTA INC's average analyst price target is greater than 2006.09% of them.

In the Pharmaceutical Products industry, ALXO, STTK, and PRAX are the three stocks most similar to NKARTA INC regarding the price target and analyst recommendation information presented here.

Is NKTX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7119 seconds.